|
|||||
|
|
Risk of Metabolic Complications in Kidney Transplantation After Conversion to mTOR Inhibitor: A Systematic Review and Meta‐Analysis |
|
| Authors: | N. Murakami T. Funakoshi |
| Affiliation: | Department of Medicine, Beth Israel Medical Center, , New York, NY |
| Abstract: | |
| Keywords: | Calcineurin inhibitor (CNI) clinical research/practice complication: medical/metabolic immunosuppressant immunosuppression/immune modulation immunosuppressive regimens kidney transplantation/nephrology mechanistic target of rapamycin (mTOR) minimization/withdrawal |